DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that the first patient in the United States has been enrolled in the Extended Access Registry, a single arm study of its Tryton Side Branch Stent. The Tryton registry is designed to confirm the results from its Pivotal IDE Trial and is expected to enroll 133 patients from Europe and the United States. The first patient in the U.S. was enrolled by Jeffrey W. Moses, M.D., Director Cardiovascular Interventions New York Presbyterian Hospital/Columbia University Medical Center & Professor of Medicine Columbia University College of Physician and Surgeons.
Help employers find you! Check out all the jobs and post your resume.
